CS logo
small CS logo
Women's Cancer Center of Seattle

Seattle, Washington, United States
Cancer treatment center in Seattle, Washington
1221 Madison St 5th & 6th Floor, Seattle, WA 98104

About Women's Cancer Center of Seattle


"A woman’s physiology is different from a man’s. So, too, is her body’s response to cancer, chemotherapy, radiation and other treatments. That is why we opened the True Family Women’s Cancer Center. Our specialists focus exclusively on treating women with cancer, and the True Center offers a tremendous number of ways to give emotional support to women and their families."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Women's Cancer Center of Seattle


During the past decade, Women's Cancer Center of Seattle conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Cancer Center of Seattle" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Women's Cancer Center of Seattle


According to Clinical.Site data, the most researched conditions in "Women's Cancer Center of Seattle" are "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials), "Ovarian Clear Cell Adenocarcinoma" (4 trials), "Ovarian Seromucinous Carcinoma" (4 trials) and "Ovarian Serous Adenocarcinoma" (4 trials). Many other conditions were trialed in "Women's Cancer Center of Seattle" in a lesser frequency.

Clinical Trials Intervention Types at Women's Cancer Center of Seattle


Most popular intervention types in "Women's Cancer Center of Seattle" are "Other" (9 trials), "Drug" (6 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Laboratory Biomarker Analysis" (6 trials), "Questionnaire Administration" (6 trials), "Paclitaxel" (5 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Women's Cancer Center of Seattle


The vast majority of trials in "Women's Cancer Center of Seattle" are 9 trials for "Female" genders.

Clinical Trials Status at Women's Cancer Center of Seattle


Currently, there are NaN active trials in "Women's Cancer Center of Seattle". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Women's Cancer Center of Seattle, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Women's Cancer Center of Seattle, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".